Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomised Controlled Trial on Flufenamic Acid for Hospitalised Influenza Infection

NCT03238612 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03238612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomised Controlled Trial on Flufenamic Acid for Hospitalised Influenza Infection
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Unknown status
Start date
January 8, 2018
Completion date
October 31, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a